Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | 0.00% | +12.50% | +125.00% |
Valuation
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 133.8 | 7.579 | 2.526 | 14.07 | - |
Enterprise Value (EV) 1 | 133.8 | 7.579 | 2.526 | 14.07 | 14.07 |
P/E ratio | - | -1 x | - | -45 x | 45 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 11.7 x | - | 0.26 x | 1.13 x | 1.01 x |
EV / Revenue | 11.7 x | - | 0.26 x | 1.13 x | 1.01 x |
EV / EBITDA | -8.96 x | - | 4.89 x | 11.3 x | 8.42 x |
EV / FCF | - | - | - | 18.8 x | - |
FCF Yield | - | - | - | 5.32% | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 185,820 | 252,618 | 252,618 | 312,618 | - |
Reference price 2 | 0.7200 | 0.0300 | 0.0100 | 0.0450 | 0.0450 |
Announcement Date | 19-10-28 | 22-10-28 | 23-10-18 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 11.46 | - | 9.791 | 12.44 | 13.93 |
EBITDA 1 | -14.94 | - | 0.517 | 1.243 | 1.671 |
EBIT 1 | - | - | -0.813 | -0.106 | 0.294 |
Operating Margin | - | - | -8.3% | -0.85% | 2.11% |
Earnings before Tax (EBT) 1 | - | - | - | -0.224 | 0.177 |
Net income 1 | - | -7.009 | - | -0.224 | 0.163 |
Net margin | - | - | - | -1.8% | 1.17% |
EPS 2 | - | -0.0300 | - | -0.001000 | 0.001000 |
Free Cash Flow 1 | - | - | - | 0.749 | - |
FCF margin | - | - | - | 6.02% | - |
FCF Conversion (EBITDA) | - | - | - | 60.26% | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 19-10-28 | 22-10-28 | 23-10-18 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2023 Q3 |
---|---|
Net sales | - |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | -0.685 |
Net margin | - |
EPS 2 | -0.003000 |
Dividend per Share | - |
Announcement Date | 23-05-23 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | 0.75 | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | - | 0.1 | 0.1 |
Capex / Sales | - | - | - | 0.8% | 0.72% |
Announcement Date | 19-10-28 | 22-10-28 | 23-10-18 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+125.00% | 10.3M | |
+131.68% | 2.18B | |
+131.75% | 76.48M |
- Stock Market
- Equities
- DHB Stock
- Financials Delivra Health Brands Inc.